Nasus Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nasus Pharma and other ETFs, options, and stocks.About NSRX
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats.
CEODan Teleman
CEODan Teleman
Employees5
Employees5
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2019
Founded2019
Employees5
Employees5
NSRX Key Statistics
Market cap59.00M
Market cap59.00M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.09K
Average volume1.09K
High today$6.85
High today$6.85
Low today$6.85
Low today$6.85
Open price$6.85
Open price$6.85
Volume427.00
Volume427.00
52 Week high$9.99
52 Week high$9.99
52 Week low$5.90
52 Week low$5.90
Stock Snapshot
With a market cap of 59M, Nasus Pharma(NSRX) trades at $6.85.
During the trading session on 2025-12-04, Nasus Pharma(NSRX) shares reached a daily high of $6.85 and a low of $6.85. At a current price of $6.85, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading volume for Nasus Pharma(NSRX) stock has reached 427, versus its average volume of 1.09K.
Over the past 52 weeks, Nasus Pharma(NSRX) stock has traded between a high of $9.99 and a low of $5.90.
Over the past 52 weeks, Nasus Pharma(NSRX) stock has traded between a high of $9.99 and a low of $5.90.
People also own
Based on the portfolios of people who own NSRX. This list is generated using Robinhood data, and it’s not a recommendation.